nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—Propranolol—Levobunolol—glaucoma	0.138	0.276	CrCrCtD
Cinacalcet—Propranolol—Carteolol—glaucoma	0.138	0.276	CrCrCtD
Cinacalcet—Propranolol—Metipranolol—glaucoma	0.132	0.263	CrCrCtD
Cinacalcet—Propranolol—Betaxolol—glaucoma	0.0922	0.184	CrCrCtD
Cinacalcet—CYP2D6—Carteolol—glaucoma	0.0549	0.159	CbGbCtD
Cinacalcet—CYP1A2—Betaxolol—glaucoma	0.045	0.13	CbGbCtD
Cinacalcet—CYP2D6—Betaxolol—glaucoma	0.0371	0.107	CbGbCtD
Cinacalcet—CYP2D6—Methazolamide—glaucoma	0.0281	0.0811	CbGbCtD
Cinacalcet—CYP3A4—Pilocarpine—glaucoma	0.0264	0.0764	CbGbCtD
Cinacalcet—CYP1A2—Clonidine—glaucoma	0.0247	0.0712	CbGbCtD
Cinacalcet—CYP2D6—Timolol—glaucoma	0.0239	0.069	CbGbCtD
Cinacalcet—CYP3A4—Brinzolamide—glaucoma	0.0208	0.0599	CbGbCtD
Cinacalcet—CYP2D6—Clonidine—glaucoma	0.0203	0.0587	CbGbCtD
Cinacalcet—CYP3A4—Dorzolamide—glaucoma	0.02	0.0579	CbGbCtD
Cinacalcet—CYP3A4—Methazolamide—glaucoma	0.0179	0.0516	CbGbCtD
Cinacalcet—CYP3A4—Acetazolamide—glaucoma	0.0143	0.0413	CbGbCtD
Cinacalcet—CYP3A4—Clonidine—glaucoma	0.0129	0.0373	CbGbCtD
Cinacalcet—CASR—G alpha (q) signalling events—OPN4—glaucoma	0.00102	0.0653	CbGpPWpGaD
Cinacalcet—CASR—G alpha (q) signalling events—PTGFR—glaucoma	0.00092	0.0588	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.000914	0.0584	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000823	0.0526	CbGpPWpGaD
Cinacalcet—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.000523	0.0334	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—OPN4—glaucoma	0.000515	0.0329	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—PTGFR—glaucoma	0.000464	0.0296	CbGpPWpGaD
Cinacalcet—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000359	0.023	CbGpPWpGaD
Cinacalcet—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000327	0.0209	CbGpPWpGaD
Cinacalcet—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00032	0.0204	CbGpPWpGaD
Cinacalcet—Nausea—Carbachol—glaucoma	0.000308	0.00224	CcSEcCtD
Cinacalcet—Infection—Travoprost—glaucoma	0.000307	0.00224	CcSEcCtD
Cinacalcet—Headache—Methazolamide—glaucoma	0.000306	0.00223	CcSEcCtD
Cinacalcet—CASR—G alpha (q) signalling events—EDN1—glaucoma	0.000306	0.0195	CbGpPWpGaD
Cinacalcet—Myalgia—Pilocarpine—glaucoma	0.000306	0.00223	CcSEcCtD
Cinacalcet—Arthralgia—Pilocarpine—glaucoma	0.000306	0.00223	CcSEcCtD
Cinacalcet—Chest pain—Pilocarpine—glaucoma	0.000306	0.00223	CcSEcCtD
Cinacalcet—Paraesthesia—Acetazolamide—glaucoma	0.000304	0.00222	CcSEcCtD
Cinacalcet—Hypotension—Brimonidine—glaucoma	0.000303	0.00221	CcSEcCtD
Cinacalcet—Nausea—Levobunolol—glaucoma	0.000303	0.00221	CcSEcCtD
Cinacalcet—Infection—Brinzolamide—glaucoma	0.000303	0.00221	CcSEcCtD
Cinacalcet—Nervous system disorder—Travoprost—glaucoma	0.000303	0.00221	CcSEcCtD
Cinacalcet—Skin disorder—Travoprost—glaucoma	0.0003	0.00219	CcSEcCtD
Cinacalcet—Abdominal pain—Apraclonidine—glaucoma	0.000299	0.00218	CcSEcCtD
Cinacalcet—Nervous system disorder—Brinzolamide—glaucoma	0.000299	0.00218	CcSEcCtD
Cinacalcet—Rash—Latanoprost—glaucoma	0.000298	0.00218	CcSEcCtD
Cinacalcet—Dermatitis—Latanoprost—glaucoma	0.000298	0.00217	CcSEcCtD
Cinacalcet—Dyspepsia—Acetazolamide—glaucoma	0.000298	0.00217	CcSEcCtD
Cinacalcet—Headache—Latanoprost—glaucoma	0.000296	0.00216	CcSEcCtD
Cinacalcet—Skin disorder—Brinzolamide—glaucoma	0.000296	0.00216	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000296	0.00216	CcSEcCtD
Cinacalcet—Anorexia—Dorzolamide—glaucoma	0.000295	0.00216	CcSEcCtD
Cinacalcet—Arrhythmia—Clonidine—glaucoma	0.000294	0.00215	CcSEcCtD
Cinacalcet—Decreased appetite—Acetazolamide—glaucoma	0.000294	0.00214	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000292	0.00213	CcSEcCtD
Cinacalcet—Fatigue—Acetazolamide—glaucoma	0.000292	0.00213	CcSEcCtD
Cinacalcet—Paraesthesia—Brimonidine—glaucoma	0.000291	0.00213	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—OPN4—glaucoma	0.000291	0.0186	CbGpPWpGaD
Cinacalcet—Infection—Pilocarpine—glaucoma	0.000291	0.00212	CcSEcCtD
Cinacalcet—Nausea—Methazolamide—glaucoma	0.00029	0.00212	CcSEcCtD
Cinacalcet—Hypotension—Dorzolamide—glaucoma	0.00029	0.00211	CcSEcCtD
Cinacalcet—Dyspnoea—Brimonidine—glaucoma	0.000289	0.00211	CcSEcCtD
Cinacalcet—Hypotension—Travoprost—glaucoma	0.000288	0.0021	CcSEcCtD
Cinacalcet—Dyspepsia—Brimonidine—glaucoma	0.000286	0.00208	CcSEcCtD
Cinacalcet—Hypotension—Brinzolamide—glaucoma	0.000285	0.00208	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000282	0.00206	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Travoprost—glaucoma	0.000281	0.00205	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Brimonidine—glaucoma	0.00028	0.00204	CcSEcCtD
Cinacalcet—Fatigue—Brimonidine—glaucoma	0.00028	0.00204	CcSEcCtD
Cinacalcet—Anorexia—Pilocarpine—glaucoma	0.000279	0.00204	CcSEcCtD
Cinacalcet—Hypersensitivity—Apraclonidine—glaucoma	0.000279	0.00203	CcSEcCtD
Cinacalcet—Paraesthesia—Dorzolamide—glaucoma	0.000278	0.00203	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000278	0.00203	CcSEcCtD
Cinacalcet—Dyspnoea—Dorzolamide—glaucoma	0.000276	0.00202	CcSEcCtD
Cinacalcet—Muscle spasms—Clonidine—glaucoma	0.000276	0.00201	CcSEcCtD
Cinacalcet—Dyspnoea—Travoprost—glaucoma	0.000275	0.00201	CcSEcCtD
Cinacalcet—Hypotension—Pilocarpine—glaucoma	0.000274	0.002	CcSEcCtD
Cinacalcet—Paraesthesia—Brinzolamide—glaucoma	0.000274	0.002	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000273	0.0175	CbGpPWpGaD
Cinacalcet—Dyspepsia—Dorzolamide—glaucoma	0.000273	0.00199	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Timolol—glaucoma	0.000272	0.00198	CcSEcCtD
Cinacalcet—Dyspnoea—Brinzolamide—glaucoma	0.000272	0.00198	CcSEcCtD
Cinacalcet—Dyspepsia—Travoprost—glaucoma	0.000272	0.00198	CcSEcCtD
Cinacalcet—Asthenia—Apraclonidine—glaucoma	0.000271	0.00198	CcSEcCtD
Cinacalcet—Decreased appetite—Dorzolamide—glaucoma	0.000269	0.00197	CcSEcCtD
Cinacalcet—Urticaria—Acetazolamide—glaucoma	0.000269	0.00196	CcSEcCtD
Cinacalcet—Dyspepsia—Brinzolamide—glaucoma	0.000268	0.00196	CcSEcCtD
Cinacalcet—Pruritus—Apraclonidine—glaucoma	0.000267	0.00195	CcSEcCtD
Cinacalcet—Body temperature increased—Acetazolamide—glaucoma	0.000267	0.00195	CcSEcCtD
Cinacalcet—Fatigue—Dorzolamide—glaucoma	0.000267	0.00195	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000267	0.00195	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Travoprost—glaucoma	0.000266	0.00194	CcSEcCtD
Cinacalcet—Fatigue—Travoprost—glaucoma	0.000266	0.00194	CcSEcCtD
Cinacalcet—Decreased appetite—Brinzolamide—glaucoma	0.000265	0.00193	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—OPN4—glaucoma	0.000264	0.0169	CbGpPWpGaD
Cinacalcet—Constipation—Travoprost—glaucoma	0.000264	0.00193	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000263	0.00192	CcSEcCtD
Cinacalcet—Paraesthesia—Pilocarpine—glaucoma	0.000263	0.00192	CcSEcCtD
Cinacalcet—Asthenia—Bimatoprost—glaucoma	0.000263	0.00192	CcSEcCtD
Cinacalcet—Fatigue—Brinzolamide—glaucoma	0.000263	0.00192	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—PTGFR—glaucoma	0.000262	0.0167	CbGpPWpGaD
Cinacalcet—Angioedema—Clonidine—glaucoma	0.000262	0.00191	CcSEcCtD
Cinacalcet—Dyspnoea—Pilocarpine—glaucoma	0.000261	0.0019	CcSEcCtD
Cinacalcet—Depression—Timolol—glaucoma	0.00026	0.0019	CcSEcCtD
Cinacalcet—Pruritus—Bimatoprost—glaucoma	0.000259	0.00189	CcSEcCtD
Cinacalcet—Immune system disorder—Betaxolol—glaucoma	0.000259	0.00189	CcSEcCtD
Cinacalcet—Diarrhoea—Apraclonidine—glaucoma	0.000259	0.00189	CcSEcCtD
Cinacalcet—Dyspepsia—Pilocarpine—glaucoma	0.000258	0.00188	CcSEcCtD
Cinacalcet—Arrhythmia—Betaxolol—glaucoma	0.000256	0.00187	CcSEcCtD
Cinacalcet—Decreased appetite—Pilocarpine—glaucoma	0.000255	0.00186	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Dorzolamide—glaucoma	0.000253	0.00185	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000253	0.00184	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Travoprost—glaucoma	0.000252	0.00184	CcSEcCtD
Cinacalcet—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000252	0.0161	CbGpPWpGaD
Cinacalcet—Constipation—Pilocarpine—glaucoma	0.00025	0.00183	CcSEcCtD
Cinacalcet—Cough—Clonidine—glaucoma	0.00025	0.00182	CcSEcCtD
Cinacalcet—Dizziness—Apraclonidine—glaucoma	0.00025	0.00182	CcSEcCtD
Cinacalcet—Malnutrition—Betaxolol—glaucoma	0.000249	0.00182	CcSEcCtD
Cinacalcet—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000247	0.0158	CbGpPWpGaD
Cinacalcet—Urticaria—Dorzolamide—glaucoma	0.000246	0.0018	CcSEcCtD
Cinacalcet—Body temperature increased—Dorzolamide—glaucoma	0.000245	0.00179	CcSEcCtD
Cinacalcet—Abdominal pain—Dorzolamide—glaucoma	0.000245	0.00179	CcSEcCtD
Cinacalcet—Chest pain—Clonidine—glaucoma	0.000244	0.00178	CcSEcCtD
Cinacalcet—Arthralgia—Clonidine—glaucoma	0.000244	0.00178	CcSEcCtD
Cinacalcet—Abdominal pain—Travoprost—glaucoma	0.000244	0.00178	CcSEcCtD
Cinacalcet—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000244	0.0156	CbGpPWpGaD
Cinacalcet—Floctafenine—PTGS2—glaucoma	0.000243	1	CrCbGaD
Cinacalcet—Asthenia—Acetazolamide—glaucoma	0.000243	0.00177	CcSEcCtD
Cinacalcet—Dizziness—Bimatoprost—glaucoma	0.000242	0.00177	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000242	0.00177	CcSEcCtD
Cinacalcet—Urticaria—Brinzolamide—glaucoma	0.000242	0.00177	CcSEcCtD
Cinacalcet—Vomiting—Apraclonidine—glaucoma	0.00024	0.00175	CcSEcCtD
Cinacalcet—Muscle spasms—Betaxolol—glaucoma	0.00024	0.00175	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Pilocarpine—glaucoma	0.000239	0.00175	CcSEcCtD
Cinacalcet—Hypersensitivity—Brimonidine—glaucoma	0.000239	0.00174	CcSEcCtD
Cinacalcet—Dermatitis—Apraclonidine—glaucoma	0.000238	0.00174	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—PTGFR—glaucoma	0.000238	0.0152	CbGpPWpGaD
Cinacalcet—Headache—Apraclonidine—glaucoma	0.000237	0.00173	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—SMO—glaucoma	0.000234	0.0149	CbGpPWpGaD
Cinacalcet—Asthenia—Brimonidine—glaucoma	0.000233	0.0017	CcSEcCtD
Cinacalcet—Infection—Clonidine—glaucoma	0.000232	0.0017	CcSEcCtD
Cinacalcet—Abdominal pain—Pilocarpine—glaucoma	0.000232	0.00169	CcSEcCtD
Cinacalcet—Body temperature increased—Pilocarpine—glaucoma	0.000232	0.00169	CcSEcCtD
Cinacalcet—Diarrhoea—Acetazolamide—glaucoma	0.000231	0.00169	CcSEcCtD
Cinacalcet—Rash—Bimatoprost—glaucoma	0.000231	0.00169	CcSEcCtD
Cinacalcet—Dermatitis—Bimatoprost—glaucoma	0.000231	0.00168	CcSEcCtD
Cinacalcet—Oedema peripheral—Timolol—glaucoma	0.000231	0.00168	CcSEcCtD
Cinacalcet—Anaemia—Betaxolol—glaucoma	0.000231	0.00168	CcSEcCtD
Cinacalcet—Pruritus—Brimonidine—glaucoma	0.00023	0.00168	CcSEcCtD
Cinacalcet—Headache—Bimatoprost—glaucoma	0.00023	0.00168	CcSEcCtD
Cinacalcet—Nervous system disorder—Clonidine—glaucoma	0.000229	0.00167	CcSEcCtD
Cinacalcet—Hypersensitivity—Dorzolamide—glaucoma	0.000228	0.00167	CcSEcCtD
Cinacalcet—Hypersensitivity—Travoprost—glaucoma	0.000227	0.00166	CcSEcCtD
Cinacalcet—Skin disorder—Clonidine—glaucoma	0.000227	0.00166	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—LRP12—glaucoma	0.000225	0.0144	CbGpPWpGaD
Cinacalcet—Nausea—Apraclonidine—glaucoma	0.000225	0.00164	CcSEcCtD
Cinacalcet—Hypersensitivity—Brinzolamide—glaucoma	0.000224	0.00164	CcSEcCtD
Cinacalcet—Dizziness—Acetazolamide—glaucoma	0.000224	0.00163	CcSEcCtD
Cinacalcet—Anorexia—Clonidine—glaucoma	0.000223	0.00163	CcSEcCtD
Cinacalcet—CASR—G alpha (i) signalling events—C3—glaucoma	0.000222	0.0142	CbGpPWpGaD
Cinacalcet—Asthenia—Dorzolamide—glaucoma	0.000222	0.00162	CcSEcCtD
Cinacalcet—Asthenia—Travoprost—glaucoma	0.000221	0.00162	CcSEcCtD
Cinacalcet—Pruritus—Dorzolamide—glaucoma	0.000219	0.0016	CcSEcCtD
Cinacalcet—Asthenia—Brinzolamide—glaucoma	0.000219	0.0016	CcSEcCtD
Cinacalcet—Hypotension—Clonidine—glaucoma	0.000219	0.00159	CcSEcCtD
Cinacalcet—Pruritus—Travoprost—glaucoma	0.000218	0.00159	CcSEcCtD
Cinacalcet—Cough—Betaxolol—glaucoma	0.000218	0.00159	CcSEcCtD
Cinacalcet—Nausea—Bimatoprost—glaucoma	0.000218	0.00159	CcSEcCtD
Cinacalcet—Hypersensitivity—Pilocarpine—glaucoma	0.000216	0.00157	CcSEcCtD
Cinacalcet—Pruritus—Brinzolamide—glaucoma	0.000216	0.00157	CcSEcCtD
Cinacalcet—Vomiting—Acetazolamide—glaucoma	0.000215	0.00157	CcSEcCtD
Cinacalcet—Dizziness—Brimonidine—glaucoma	0.000215	0.00157	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Clonidine—glaucoma	0.000213	0.00155	CcSEcCtD
Cinacalcet—Myalgia—Betaxolol—glaucoma	0.000212	0.00155	CcSEcCtD
Cinacalcet—Arthralgia—Betaxolol—glaucoma	0.000212	0.00155	CcSEcCtD
Cinacalcet—Chest pain—Betaxolol—glaucoma	0.000212	0.00155	CcSEcCtD
Cinacalcet—Diarrhoea—Dorzolamide—glaucoma	0.000212	0.00155	CcSEcCtD
Cinacalcet—Headache—Acetazolamide—glaucoma	0.000212	0.00155	CcSEcCtD
Cinacalcet—Immune system disorder—Timolol—glaucoma	0.000211	0.00154	CcSEcCtD
Cinacalcet—Diarrhoea—Travoprost—glaucoma	0.000211	0.00154	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000211	0.00154	CcSEcCtD
Cinacalcet—Asthenia—Pilocarpine—glaucoma	0.00021	0.00153	CcSEcCtD
Cinacalcet—Paraesthesia—Clonidine—glaucoma	0.00021	0.00153	CcSEcCtD
Cinacalcet—Arrhythmia—Timolol—glaucoma	0.000209	0.00153	CcSEcCtD
Cinacalcet—Dyspnoea—Clonidine—glaucoma	0.000209	0.00152	CcSEcCtD
Cinacalcet—Diarrhoea—Brinzolamide—glaucoma	0.000208	0.00152	CcSEcCtD
Cinacalcet—Pruritus—Pilocarpine—glaucoma	0.000207	0.00151	CcSEcCtD
Cinacalcet—Dizziness—Dorzolamide—glaucoma	0.000205	0.0015	CcSEcCtD
Cinacalcet—Rash—Brimonidine—glaucoma	0.000205	0.00149	CcSEcCtD
Cinacalcet—Dermatitis—Brimonidine—glaucoma	0.000204	0.00149	CcSEcCtD
Cinacalcet—Dizziness—Travoprost—glaucoma	0.000204	0.00149	CcSEcCtD
Cinacalcet—Malnutrition—Timolol—glaucoma	0.000204	0.00149	CcSEcCtD
Cinacalcet—Headache—Brimonidine—glaucoma	0.000203	0.00148	CcSEcCtD
Cinacalcet—Decreased appetite—Clonidine—glaucoma	0.000203	0.00148	CcSEcCtD
Cinacalcet—Infection—Betaxolol—glaucoma	0.000202	0.00148	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Clonidine—glaucoma	0.000202	0.00147	CcSEcCtD
Cinacalcet—Fatigue—Clonidine—glaucoma	0.000202	0.00147	CcSEcCtD
Cinacalcet—Dizziness—Brinzolamide—glaucoma	0.000201	0.00147	CcSEcCtD
Cinacalcet—Nausea—Acetazolamide—glaucoma	0.000201	0.00147	CcSEcCtD
Cinacalcet—Diarrhoea—Pilocarpine—glaucoma	0.0002	0.00146	CcSEcCtD
Cinacalcet—Constipation—Clonidine—glaucoma	0.0002	0.00146	CcSEcCtD
Cinacalcet—Nervous system disorder—Betaxolol—glaucoma	0.0002	0.00146	CcSEcCtD
Cinacalcet—Skin disorder—Betaxolol—glaucoma	0.000198	0.00144	CcSEcCtD
Cinacalcet—Vomiting—Dorzolamide—glaucoma	0.000197	0.00144	CcSEcCtD
Cinacalcet—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	0.000196	0.0125	CbGpPWpGaD
Cinacalcet—Rash—Dorzolamide—glaucoma	0.000195	0.00143	CcSEcCtD
Cinacalcet—Dermatitis—Dorzolamide—glaucoma	0.000195	0.00142	CcSEcCtD
Cinacalcet—Rash—Travoprost—glaucoma	0.000195	0.00142	CcSEcCtD
Cinacalcet—Dermatitis—Travoprost—glaucoma	0.000194	0.00142	CcSEcCtD
Cinacalcet—Headache—Dorzolamide—glaucoma	0.000194	0.00142	CcSEcCtD
Cinacalcet—Anorexia—Betaxolol—glaucoma	0.000194	0.00142	CcSEcCtD
Cinacalcet—Vomiting—Brinzolamide—glaucoma	0.000194	0.00141	CcSEcCtD
Cinacalcet—Dizziness—Pilocarpine—glaucoma	0.000194	0.00141	CcSEcCtD
Cinacalcet—Headache—Travoprost—glaucoma	0.000193	0.00141	CcSEcCtD
Cinacalcet—Nausea—Brimonidine—glaucoma	0.000193	0.00141	CcSEcCtD
Cinacalcet—Rash—Brinzolamide—glaucoma	0.000192	0.0014	CcSEcCtD
Cinacalcet—Dermatitis—Brinzolamide—glaucoma	0.000192	0.0014	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Clonidine—glaucoma	0.000191	0.0014	CcSEcCtD
Cinacalcet—Headache—Brinzolamide—glaucoma	0.000191	0.00139	CcSEcCtD
Cinacalcet—Hypotension—Betaxolol—glaucoma	0.00019	0.00139	CcSEcCtD
Cinacalcet—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000188	0.012	CbGpPWpGaD
Cinacalcet—Angioedema—Timolol—glaucoma	0.000186	0.00136	CcSEcCtD
Cinacalcet—Vomiting—Pilocarpine—glaucoma	0.000186	0.00136	CcSEcCtD
Cinacalcet—Urticaria—Clonidine—glaucoma	0.000186	0.00136	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000186	0.00135	CcSEcCtD
Cinacalcet—Body temperature increased—Clonidine—glaucoma	0.000185	0.00135	CcSEcCtD
Cinacalcet—Abdominal pain—Clonidine—glaucoma	0.000185	0.00135	CcSEcCtD
Cinacalcet—Rash—Pilocarpine—glaucoma	0.000185	0.00135	CcSEcCtD
Cinacalcet—Dermatitis—Pilocarpine—glaucoma	0.000184	0.00135	CcSEcCtD
Cinacalcet—Nausea—Dorzolamide—glaucoma	0.000184	0.00134	CcSEcCtD
Cinacalcet—Headache—Pilocarpine—glaucoma	0.000183	0.00134	CcSEcCtD
Cinacalcet—Nausea—Travoprost—glaucoma	0.000183	0.00134	CcSEcCtD
Cinacalcet—Paraesthesia—Betaxolol—glaucoma	0.000183	0.00133	CcSEcCtD
Cinacalcet—Dyspnoea—Betaxolol—glaucoma	0.000182	0.00132	CcSEcCtD
Cinacalcet—Nausea—Brinzolamide—glaucoma	0.000181	0.00132	CcSEcCtD
Cinacalcet—Dyspepsia—Betaxolol—glaucoma	0.000179	0.00131	CcSEcCtD
Cinacalcet—Cough—Timolol—glaucoma	0.000178	0.0013	CcSEcCtD
Cinacalcet—Decreased appetite—Betaxolol—glaucoma	0.000177	0.00129	CcSEcCtD
Cinacalcet—Hypertension—Timolol—glaucoma	0.000176	0.00128	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Betaxolol—glaucoma	0.000176	0.00128	CcSEcCtD
Cinacalcet—Fatigue—Betaxolol—glaucoma	0.000176	0.00128	CcSEcCtD
Cinacalcet—Constipation—Betaxolol—glaucoma	0.000174	0.00127	CcSEcCtD
Cinacalcet—Nausea—Pilocarpine—glaucoma	0.000174	0.00127	CcSEcCtD
Cinacalcet—Arthralgia—Timolol—glaucoma	0.000174	0.00127	CcSEcCtD
Cinacalcet—Chest pain—Timolol—glaucoma	0.000174	0.00127	CcSEcCtD
Cinacalcet—Myalgia—Timolol—glaucoma	0.000174	0.00127	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000172	0.00126	CcSEcCtD
Cinacalcet—Hypersensitivity—Clonidine—glaucoma	0.000172	0.00126	CcSEcCtD
Cinacalcet—Asthenia—Clonidine—glaucoma	0.000168	0.00122	CcSEcCtD
Cinacalcet—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000166	0.0106	CbGpPWpGaD
Cinacalcet—Pruritus—Clonidine—glaucoma	0.000165	0.00121	CcSEcCtD
Cinacalcet—Infection—Timolol—glaucoma	0.000165	0.00121	CcSEcCtD
Cinacalcet—Nervous system disorder—Timolol—glaucoma	0.000163	0.00119	CcSEcCtD
Cinacalcet—Urticaria—Betaxolol—glaucoma	0.000162	0.00118	CcSEcCtD
Cinacalcet—Skin disorder—Timolol—glaucoma	0.000162	0.00118	CcSEcCtD
Cinacalcet—Body temperature increased—Betaxolol—glaucoma	0.000161	0.00117	CcSEcCtD
Cinacalcet—Diarrhoea—Clonidine—glaucoma	0.00016	0.00117	CcSEcCtD
Cinacalcet—Anorexia—Timolol—glaucoma	0.000159	0.00116	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—OPN4—glaucoma	0.000156	0.00998	CbGpPWpGaD
Cinacalcet—Hypotension—Timolol—glaucoma	0.000155	0.00113	CcSEcCtD
Cinacalcet—Dizziness—Clonidine—glaucoma	0.000155	0.00113	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—EDN1—glaucoma	0.000154	0.00985	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Timolol—glaucoma	0.000152	0.00111	CcSEcCtD
Cinacalcet—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000151	0.00967	CbGpPWpGaD
Cinacalcet—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.00015	0.00959	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Betaxolol—glaucoma	0.00015	0.00109	CcSEcCtD
Cinacalcet—Paraesthesia—Timolol—glaucoma	0.000149	0.00109	CcSEcCtD
Cinacalcet—Vomiting—Clonidine—glaucoma	0.000149	0.00108	CcSEcCtD
Cinacalcet—Dyspnoea—Timolol—glaucoma	0.000148	0.00108	CcSEcCtD
Cinacalcet—Rash—Clonidine—glaucoma	0.000147	0.00108	CcSEcCtD
Cinacalcet—Dermatitis—Clonidine—glaucoma	0.000147	0.00107	CcSEcCtD
Cinacalcet—Headache—Clonidine—glaucoma	0.000147	0.00107	CcSEcCtD
Cinacalcet—Dyspepsia—Timolol—glaucoma	0.000146	0.00107	CcSEcCtD
Cinacalcet—Asthenia—Betaxolol—glaucoma	0.000146	0.00107	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—HEYL—glaucoma	0.000145	0.00928	CbGpPWpGaD
Cinacalcet—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000145	0.00926	CbGpPWpGaD
Cinacalcet—Decreased appetite—Timolol—glaucoma	0.000145	0.00105	CcSEcCtD
Cinacalcet—Pruritus—Betaxolol—glaucoma	0.000144	0.00105	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Timolol—glaucoma	0.000144	0.00105	CcSEcCtD
Cinacalcet—Fatigue—Timolol—glaucoma	0.000143	0.00105	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—PTGFR—glaucoma	0.000141	0.00898	CbGpPWpGaD
Cinacalcet—Diarrhoea—Betaxolol—glaucoma	0.000139	0.00102	CcSEcCtD
Cinacalcet—Nausea—Clonidine—glaucoma	0.000139	0.00101	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Timolol—glaucoma	0.000136	0.000992	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—C3—glaucoma	0.000135	0.00861	CbGpPWpGaD
Cinacalcet—Dizziness—Betaxolol—glaucoma	0.000135	0.000982	CcSEcCtD
Cinacalcet—Urticaria—Timolol—glaucoma	0.000132	0.000964	CcSEcCtD
Cinacalcet—Body temperature increased—Timolol—glaucoma	0.000131	0.000959	CcSEcCtD
Cinacalcet—Abdominal pain—Timolol—glaucoma	0.000131	0.000959	CcSEcCtD
Cinacalcet—Vomiting—Betaxolol—glaucoma	0.000129	0.000945	CcSEcCtD
Cinacalcet—Rash—Betaxolol—glaucoma	0.000128	0.000937	CcSEcCtD
Cinacalcet—Dermatitis—Betaxolol—glaucoma	0.000128	0.000936	CcSEcCtD
Cinacalcet—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000128	0.00819	CbGpPWpGaD
Cinacalcet—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000128	0.00818	CbGpPWpGaD
Cinacalcet—Headache—Betaxolol—glaucoma	0.000128	0.000931	CcSEcCtD
Cinacalcet—Hypersensitivity—Timolol—glaucoma	0.000123	0.000894	CcSEcCtD
Cinacalcet—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	0.000122	0.00782	CbGpPWpGaD
Cinacalcet—Nausea—Betaxolol—glaucoma	0.000121	0.000882	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—SMO—glaucoma	0.00012	0.00767	CbGpPWpGaD
Cinacalcet—Asthenia—Timolol—glaucoma	0.000119	0.000871	CcSEcCtD
Cinacalcet—Pruritus—Timolol—glaucoma	0.000118	0.000859	CcSEcCtD
Cinacalcet—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000116	0.0074	CbGpPWpGaD
Cinacalcet—Diarrhoea—Timolol—glaucoma	0.000114	0.00083	CcSEcCtD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000113	0.00721	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—RPTOR—glaucoma	0.00011	0.00703	CbGpPWpGaD
Cinacalcet—Dizziness—Timolol—glaucoma	0.00011	0.000803	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—NCK2—glaucoma	0.000107	0.00681	CbGpPWpGaD
Cinacalcet—Vomiting—Timolol—glaucoma	0.000106	0.000772	CcSEcCtD
Cinacalcet—Rash—Timolol—glaucoma	0.000105	0.000765	CcSEcCtD
Cinacalcet—Dermatitis—Timolol—glaucoma	0.000105	0.000764	CcSEcCtD
Cinacalcet—Headache—Timolol—glaucoma	0.000104	0.00076	CcSEcCtD
Cinacalcet—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000104	0.00662	CbGpPWpGaD
Cinacalcet—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	9.95e-05	0.00636	CbGpPWpGaD
Cinacalcet—Nausea—Timolol—glaucoma	9.88e-05	0.000721	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—HDAC9—glaucoma	9.06e-05	0.00579	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	8.86e-05	0.00566	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	8.86e-05	0.00566	CbGpPWpGaD
Cinacalcet—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	8.86e-05	0.00566	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—EDN1—glaucoma	8.71e-05	0.00557	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	8.71e-05	0.00557	CbGpPWpGaD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.46e-05	0.00541	CbGpPWpGaD
Cinacalcet—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	8.43e-05	0.00539	CbGpPWpGaD
Cinacalcet—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.35e-05	0.00533	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	8.29e-05	0.0053	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—EDN1—glaucoma	7.91e-05	0.00506	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—C3—glaucoma	7.61e-05	0.00486	CbGpPWpGaD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.17e-05	0.00458	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SMO—glaucoma	7.09e-05	0.00453	CbGpPWpGaD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.07e-05	0.00452	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—C3—glaucoma	6.91e-05	0.00442	CbGpPWpGaD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.86e-05	0.00438	CbGpPWpGaD
Cinacalcet—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	6.84e-05	0.00437	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—GSTT1—glaucoma	6.62e-05	0.00423	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NTRK2—glaucoma	6.48e-05	0.00414	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.81e-05	0.00371	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NGFR—glaucoma	5.56e-05	0.00356	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.53e-05	0.00353	CbGpPWpGaD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.46e-05	0.00349	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NTRK1—glaucoma	5.29e-05	0.00338	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CDKN2B—glaucoma	4.87e-05	0.00311	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EDN1—glaucoma	4.67e-05	0.00299	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTT1—glaucoma	4.57e-05	0.00292	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.48e-05	0.00286	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NGF—glaucoma	4.3e-05	0.00274	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—GSTM1—glaucoma	4.22e-05	0.00269	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—C3—glaucoma	4.08e-05	0.00261	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	3.99e-05	0.00255	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTT1—glaucoma	3.87e-05	0.00247	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—APOE—glaucoma	3.8e-05	0.00243	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	3.78e-05	0.00242	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	3.78e-05	0.00242	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CAV1—glaucoma	3.77e-05	0.00241	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	3.74e-05	0.00239	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP1B1—glaucoma	3.64e-05	0.00233	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	3.59e-05	0.0023	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—FN1—glaucoma	3.59e-05	0.00229	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—BAD—glaucoma	3.54e-05	0.00226	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CA5A—glaucoma	3.2e-05	0.00205	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NARFL—glaucoma	3.2e-05	0.00205	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	3.15e-05	0.00201	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP1B1—glaucoma	3.09e-05	0.00197	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	3.04e-05	0.00194	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.99e-05	0.00191	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.91e-05	0.00186	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.88e-05	0.00184	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.87e-05	0.00184	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NOS3—glaucoma	2.85e-05	0.00182	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CA5A—glaucoma	2.71e-05	0.00173	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NARFL—glaucoma	2.71e-05	0.00173	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	2.7e-05	0.00172	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	2.7e-05	0.00172	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CDKN1B—glaucoma	2.47e-05	0.00158	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTM1—glaucoma	2.47e-05	0.00158	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	2.43e-05	0.00155	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.38e-05	0.00152	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.35e-05	0.0015	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MMP9—glaucoma	2.29e-05	0.00146	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CA5A—glaucoma	2.09e-05	0.00134	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NARFL—glaucoma	2.09e-05	0.00134	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VEGFA—glaucoma	2.05e-05	0.00131	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.9e-05	0.00122	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.88e-05	0.0012	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CA1—glaucoma	1.56e-05	0.001	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TP53—glaucoma	1.55e-05	0.000991	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CTSA—glaucoma	1.52e-05	0.000968	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CA2—glaucoma	1.43e-05	0.000914	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CA1—glaucoma	1.33e-05	0.000847	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CTSA—glaucoma	1.28e-05	0.00082	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CA2—glaucoma	1.21e-05	0.000775	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.18e-05	0.000757	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.18e-05	0.000757	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CA1—glaucoma	1.02e-05	0.000654	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TXN—glaucoma	1.01e-05	0.000644	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CTSA—glaucoma	9.91e-06	0.000633	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CA2—glaucoma	9.36e-06	0.000598	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TXN—glaucoma	8.54e-06	0.000546	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTT1—glaucoma	7.82e-06	0.0005	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.79e-06	0.000498	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.72e-06	0.000493	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTT1—glaucoma	6.62e-06	0.000423	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TXN—glaucoma	6.59e-06	0.000421	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP1B1—glaucoma	6.23e-06	0.000398	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ABCA1—glaucoma	6.23e-06	0.000398	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.34e-06	0.000341	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ABCA1—glaucoma	5.28e-06	0.000337	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP1B1—glaucoma	5.28e-06	0.000337	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTT1—glaucoma	5.11e-06	0.000327	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTM1—glaucoma	4.98e-06	0.000318	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MTHFR—glaucoma	4.4e-06	0.000281	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTM1—glaucoma	4.22e-06	0.00027	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—APOE—glaucoma	4.1e-06	0.000262	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP1B1—glaucoma	4.07e-06	0.00026	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ABCA1—glaucoma	4.07e-06	0.00026	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CAV1—glaucoma	4.06e-06	0.000259	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MTHFR—glaucoma	3.73e-06	0.000238	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—APOE—glaucoma	3.47e-06	0.000222	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CAV1—glaucoma	3.44e-06	0.00022	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTM1—glaucoma	3.26e-06	0.000208	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NOS3—glaucoma	3.07e-06	0.000196	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MTHFR—glaucoma	2.88e-06	0.000184	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTGS2—glaucoma	2.81e-06	0.000179	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—APOE—glaucoma	2.68e-06	0.000171	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CAV1—glaucoma	2.65e-06	0.00017	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NOS3—glaucoma	2.6e-06	0.000166	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTGS2—glaucoma	2.38e-06	0.000152	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NOS3—glaucoma	2.01e-06	0.000128	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTGS2—glaucoma	1.84e-06	0.000117	CbGpPWpGaD
